Literature DB >> 8922124

Oligomeganephronic renal hypoplasia.

M Broyer1, B Soto, M F Gagnadoux, M Adi, C Rica, M C Gubler.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 8922124

Source DB:  PubMed          Journal:  Adv Nephrol Necker Hosp        ISSN： 0084-5957


× No keyword cloud information.
  7 in total

1.  Oligomeganephronia in an adult without end stage renal failure.

Authors:  Yoshinobu Fuke; Seiichiro Hemmi; Mamiko Kajiwara; Minako Yabuki; Takayuki Fujita; Masayoshi Soma
Journal:  Clin Exp Nephrol       Date:  2011-11-25       Impact factor: 2.801

2.  Clinical and pathological investigation of oligomeganephronia.

Authors:  Hideaki Kitakado; Tomoko Horinouchi; Chika Masuda; Atsushi Kondo; Sadayuki Nagai; Yuya Aoto; Nana Sakakibara; Takeshi Ninchoji; Norishige Yoshikawa; Kandai Nozu
Journal:  Pediatr Nephrol       Date:  2022-07-21       Impact factor: 3.651

3.  Utility of glomerular morphometry in diagnosing pediatric renal disease.

Authors:  A W Kashif; Nisha Verma; Shipra Verma; Dibyajyoti Boruah; Rajesh Sahu; Suprita Kalra; Ajay Malik
Journal:  Med J Armed Forces India       Date:  2020-08-26

4.  Towards a definition of glomerulomegaly: clinical-pathological and methodological considerations.

Authors:  Michael D Hughson; Wendy E Hoy; Rebecca N Douglas-Denton; Monika A Zimanyi; John F Bertram
Journal:  Nephrol Dial Transplant       Date:  2010-11-29       Impact factor: 5.992

5.  Congenital oligomeganephronia: computed tomography appearance.

Authors:  Katharine Hopkins; Jeanne Mowry; Donald Houghton
Journal:  Clin Pract       Date:  2013-11-08

Review 6.  A Case Report and Literature Review of Oligomeganephronia.

Authors:  Xu-Hao Wang; Lei Pan; Shan He; De-Lei Kong; Wei Wang
Journal:  Front Med (Lausanne)       Date:  2022-03-22

Review 7.  Renal Hypoplasia, From Grossly Insufficient to Not Quite Enough: Consideration for Expanded Concepts Based Upon the Author's Perspective With Historical Review.

Authors:  Stephen M Bonsib
Journal:  Adv Anat Pathol       Date:  2020-09       Impact factor: 4.571
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.